What can we learn from the past? 1950’s Advertisement

Slides:



Advertisements
Similar presentations
Neos Zavrou AOD Sector Reforms. THE PROBLEM – 108+ AOD service providers Poor quality data Many barriers Poor service integration Inadequate funding Limited.
Advertisements

Background: The low retention rates among African Americans in substance abuse treatment (Milligan et al., 2004) combined with the limited number of treatments.
Suicidal behaviours among adolescents in Aotearoa: data from the Youth2000 series Dr Pete Watson and Dr Sarah Fortune on behalf of The Adolescent Health.
A Health Based Approach Within The UN Conventions: Examples Of Practice Fay Watson, Vice Chair: EU Civil Society Forum on Drugs.
ECONOMIC OVERVIEW Janet Kelly Urban Studies Institute University of Louisville.
The Me and My School survey  The first and largest section is entitled Me and My School and is concerned with a global measure of student engagement.
Alcohol, Tobacco, & Other Drugs Lesson 2 Amy Prior-Harding University High School.
‘Family ethnicity’ Should we count? How should we count? Why? Robert Didham (Statistics NZ) with Paul Callister (Victoria University of Wellington), Deb.
WelTec Nursing Forum November 2009 Raine Berry. Nursing and Addictions Coexisting Disorders The Addictions Nursing Workforce Current Treatment Situation.
NUMBER OF MENTALLY DISORDERED PERSONS ( POPULATION) Data of State Mental Health Centre of Lithuania.
Treatment system-based data collection: an integrated approach to monitoring Expert meeting: Implementation of the treatment strategy EMCDDA Lisbon,
Intervention and Treatment 8th grade Drug Unit Lesson 9 Pages D th grade Drug Unit Lesson 9 Pages D62-67.
Mental Health and Substance Abuse Services Joe Vesowate Assistant Commissioner.
Annual report 2010: the state of the drugs problem in Europe.
LAWRENCE CAMPUS WEST 100 FEDERAL CITY ROAD LAWRENCEVILLE, NJ.
CPS AND SUBSTANCE ABUSE Milton Ayala, LMSW
The NSDUH Report: National Survey on Drug Use and Health NSDUH Report Sept. 16, 2005 SAMHSA Office of Applied Studies NSDUH National Survey on.
Trends in Opioid Use and Overdose in BC: Making the case for greater availability of Take Home Naloxone programs Ashraf Amlani Harm Reduction Epidemiologist.
Midland Cancer Network 2012 Clinical Performance Conference.
Differences in drug use by ethnicity: Do they suggest inequity in access to drug treatment? March 2005 Peter Madden Senior Analyst, Matthew Hickman Senior.
Barriers & benefits: transfer of opioid- dependent people on methadone maintenance treatment from secondary to primary health care NAPCRG Tucson 2006 Felicity.
version1 Recovery Management Telephone Support Project Volunteer Training CCAR, CPAS, ERSC & DMHAS.
ETHNIC DIVERSITY.
The Internet Biographies
Nation’s First Collaborative School of Public Health
NH Statewide Addiction Crisis Line HELP (4357)
American Scorecard: Special Populations
General Practice as Part of the Solution Alcohol and Other Drugs
Clinical Committee for DMC-ODS EQRO – September 16 Mtg
2.5 times more men died by suicide than women in 2013
screening, brief intervention and referral to treatment
Straight Up Engaging Youth in Conversations about Colorado Teen Substance Misuse Data.
Problematic Alcohol Use and Traveller men.
6% of adults had used one or more illicit drugs in last 12 months.
American Scorecard: Special Populations
Dual Diagnosis MACA Masterclass A substance misuse service perspective
Recovery Housing Principles and Practice
Rodney VanDerwarker1, Kenneth H. Mayer, MD1,2, Stephen L. Boswell, MD1
Nick Wilson* (Otago University, Wellington)
World Drug Report 2011.
Harmful Effects of Drug Use
World Health Organization
Social Indicators & Equity Information System
Andy Mills Manager Complex Needs Team
MODULE 2- EPIDEMIOLOGY OF DRUG USE IN THE AMERICAS
Mission Briefing on the World Drug Report 2012
How Bad is the Opioid Epidemic?
Freya Vander Laenen STRUCTURED SESSION Costs of drug treatment
First year assessment of the French « cannabis outpatients clinics »
2017 State of C.O.R.E. performance measures.
Youth drug harm In Waikato DHB 2016 Youth drug harm Waikato DHB 2016.
Extreme Poverty, Poverty, and Near Poverty Rates for Children Under Age 5, by Living Arrangement: 2011 The data for Extreme Poverty, Poverty, and Near.
Medication use and misuse among illicit drug users in France Lisbon Addictions 2017 Paper session 31: Spotlight on the misuse of medicines Aurélie Lermenier-Jeannet.
Comparison of data from WBE with other sources
CHAPTER 3 Utilization and Volume.
Supplementary Data Tables, Utilization and Volume
Recovery from High School to Phd
National findings from the Illicit Drug Reporting System
FY18 Contract Training June 26, 2017.
Figure 1: Drug of choice, ACT,
Current conditions.
Impact of reduced copayments on GP access for injuries
German Drug and Addiction Policy
Funding for maximum impact Regional Gambling Sector forum
Harmful Effects of Drug Use
‘I’m not a lone soldier’ – A multi-disciplinary response to the management and treatment of benzodiazepine use within the general practitioner setting.
FY18 Contract Training June 26, 2017.
Recidivism Among DWI Offenders in New Mexico (Preliminary Results)
Jim Messina, Ph.D., CCMHC, NCC, DCMHS-T
Center for Behavioral Health Statistics and Quality
Presentation transcript:

What can we learn from the past? 1950’s Advertisement People who use amphetamine-type stimulants and access treatment through CADS Auckland: What we know, what we might expect in the future.   Alistair White Alcohol & Drug practitioner (methamphetamine focus) www.cads.org.nz

Community Alcohol & Drugs Services (CADS) is an Auckland regional service provided by Waitemata District Health Board Mission - Reduce alcohol & other drug (AOD) related harm in the community. Assist people who have concerns about their own, or someone else's substance use. CADS provides services for the whole Auckland region, rural and urban communities, a population of 1.4million and rising. A staff of around 200 provide outpatient counselling and group programmes, withdrawal support, including inpatient detox, opioid substitution treatment and more.

Methamphetamine is the second most used illicit (psychoactive) substance in New Zealand, as it is in Australia. We can make predictions about future treatment demand, by analysis of service data of past clients. What can population trends and estimates of methamphetamine use mean for future demand? We infer from health survey estimates of methamphetamine use. What might we as a service do differently to meet the need of people who use stimulants?

Service demand: Demand for treatment services is represented by presentations to CADS over four years; the period from July 2011 to end June 2015. Data for six month periods were extracted from existing database to track other trends. Earlier data were dis-regarded as the service changed electronic recording systems at the end of 2010. Need: An estimate of service need in the Auckland region was made based on the NZ Ministry of Health Household Health survey (2013-2014) is at 1% of the population or 3% for Maori, and NZ Census data. Need was estimated according to ethnicity. “Unmet need” is the gap - the distance between current service use and estimated population use of amphetamines.

Gap analysis by ethnicity We can see that no ethnic group has engaged in numbers near to this estimate of need. Asian peoples needs appear to be particularly un-met at this point in time. At this rate, it will take many years to meet the needs of people who use methamphetamine. This means a new generation of users is likely to arise and a methamphetamine sub-culture to remain in sections of society. estimated need treatment seeking % of needs met NZ European / Pakeha 6970 1617 23% NZ Maori 4283 781 18% Pacific peoples 1950 257 13% Asian peoples 3072 107 3% Other 156 38 24% other European 923 155 17% Middle Eastern, Latin American, African 249 35 14%

Increasing number of people seen with amphetamine diagnoses We have seen an increase in number of clients seen by the service over time. We had 6079 referrals in the 4 year time period July 2011 to June 2015. This graph shows number of clients who attended the service during each six month period.

Limitations Not all treatment seekers will come to CADS: We do not have data from other services in the Auckland region, such as residential and outpatient services and “Methhelp” nationwide phone line. Our dataset is of a real client population gathered over four years, i.e. it is as accurate as real staff records allow in a working service. The midpoint of the timeframe was when the census was completed, the population trend is continued growth. Our estimate of need is a snapshot - the small sample of the NZ household health survey. We also make the assumption that everyone who uses methamphetamines will need treatment – which is in contradiction with research on natural recovery. Alistair White CADS Auckland NZ ph 263 2000 alistair.white@waitematadhb.govt.nz www.waitematadhb.govt.nz www.cads.org.nz